A model of symptomatic infantile spasms syndrome

Neurobiology of Disease

Volumn 37, Issue 3, 2010, Pages 604-612

  Scantlebury, Morris H ^a   Galanopoulou, Aristea S ^a,b   Chudomelova, Lenka ^a   Raffo, Emmanuel ^a   Betancourth, David ^a,c   Moshé, Solomon L ^a,b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Animal model; Autism; Doxorubicin; Epilepsy; Infantile spasms; Lipopolysaccharide; Neonatal rat; p Chlorophenylalanine; West syndrome

Indexed keywords

CORTICOTROPIN; DOXORUBICIN; LIPOPOLYSACCHARIDE; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; COGNITIVE DEFECT; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HYPSARRHYTHMIA; INFANTILE SPASM; MALE; MORTALITY; NONHUMAN; PATHOGENESIS; POSTNATAL CARE; PRIORITY JOURNAL; RAT; WHITE MATTER;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANIMALS, NEWBORN; ANTIBIOTICS, ANTINEOPLASTIC; ANTICONVULSANTS; AUTISTIC DISORDER; BRAIN; BRAIN DAMAGE, CHRONIC; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FENCLONINE; HUMANS; INFANT, NEWBORN; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; NEURODEGENERATIVE DISEASES; RATS; SEROTONIN ANTAGONISTS; SPASMS, INFANTILE; VIGABATRIN;

EID: 75949111993     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.11.011     Document Type: Article

References (39)

1. Appleton R.E. West syndrome: long-term prognosis and social aspects. Brain Dev. 23 (2001) 688-691
2. Barnes C.A., Nadel L., and Honig W.K. Spatial memory deficit in senescent rats. Can. J. Psychol. 34 (1980) 29-39
3. Blumberg M.S., Karlsson K.A., Seelke A.M., and Mohns E.J. The ontogeny of mammalian sleep: a response to Frank and Heller (2003). J. Sleep. Res. 14 (2005) 91-98
4. Bolivar V.J., Walters S.R., and Phoenix J.L. Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav. Brain Res. 176 (2007) 21-26
5. Brunson K.L., Eghbal-Ahmadi M., and Baram T.Z. How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain Dev. 23 (2001) 533-538
6. Caplan R., Siddarth P., Mathern G., Vinters H., Curtiss S., Levitt J., Asarnow R., and Shields W.D. Developmental outcome with and without successful intervention. Int. Rev. Neurobiol. 49 (2002) 269-284
7. Cortez M.A., Shen L., Wu Y., Aleem I.S., Trepanier C.H., Sadeghnia H.R., Ashraf A., Kanawaty A., Liu C.C., Stewart L., and Snead III O.C. Infantile spasms and Down syndrome: a new animal model. Pediatr. Res. 65 5 (2009) 499-503
8. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 248-258
9. Dulac O., Plouin P., and Schlumberger E. Infantile spasms. In: Wyllie E. (Ed). The Treatment of Epilepsy: Principals and Practice (1997), Williams & Wilkins, Baltimore, MD 540-572
10. Goh S., Kwiatkowski D.J., Dorer D.J., and Thiele E.A. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology 65 (2005) 235-238
11. Hrachovy R.A., and Frost Jr. J.D. Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome). J. Clin. Neurophysiol. 20 (2003) 408-425
12. Jeavons P.M., Bower B.D., and Dimitrakoudi M. Long-term prognosis of 150 cases of "West syndrome". Epilepsia 14 (1973) 153-164
13. Kaindl A.M., Asimiadou S., Manthey D., Hagen M.V., Turski L., and Ikonomidou C. Antiepileptic drugs and the developing brain. Cell Mol. Life Sci. 63 (2006) 399-413
14. Kellaway P., Hrachovy R.A., Frost Jr. J.D., and Zion T. Precise characterization and quantification of infantile spasms. Ann. Neurol. 6 (1979) 214-218
15. Lado F.A., and Moshe S.L. Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators?. Int. Rev. Neurobiol. 49 (2002) 115-140
16. Lee C.L., Frost Jr. J.D., Swann J.W., and Hrachovy R.A. A new animal model of infantile spasms with unprovoked persistent seizures. Epilepsia 49 (2008) 298-307
17. Lux A.L., Edwards S.W., Hancock E., Johnson A.L., Kennedy C.R., Newton R.W., O'Callaghan F.J., Verity C.M., and Osborne J.P. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 4 (2005) 707-712
18. Mackay M.T., Weiss S.K., Adams-Webber T., Ashwal S., Stephens D., Ballaban-Gill K., Baram T.Z., Duchowny M., Hirtz D., Pellock J.M., Sheilds W.D., Shinnar S., Wyllie E., and Snead O.C. Practise parameter: medical treatment of infantile spasms. Neurology 62 (2004) 1668-1681
19. Marsh E., Fulp C., Gomez E., Nasrallah I., Minarcik J., Sudi J., Christian S.L., Mancini G., Labosky P., Dobyns W., Brooks-Kayal A., and Golden J.A. Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females. Brain 132 (2009) 1563-1576
20. Mikulecka A., and Mares P. NMDA receptor antagonists impair motor performance in immature rats. Psychopharmacology (Berl) 162 (2002) 364-372
21. Pang Y., Cai Z., and Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res. Dev. Brain Res. 140 (2003) 205-214
22. Plouin P., Dulac O., Jalin C., and Chiron C. Twenty-four-hour ambulatory EEG monitoring in infantile spasms. Epilepsia 34 (1993) 686-691
23. Price M.G., Yoo J.W., Burgess D.L., Deng F., Hrachovy R.A., Frost Jr. J.D., and Noebels J.L. A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment. J. Neurosci. 29 (2009) 8752-8763
24. Primec Z.R., Stare J., and Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia 47 (2006) 2202-2205
25. Rantala H., and Putkonen T. Occurrence, outcome, and prognostic factors of infantile spasms and Lennox-Gastaut syndrome. Epilepsia 40 (1999) 286-289
26. Rattray M., Baldessari S., Gobbi M., Mennini T., Samanin R., and Bendotti C. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J. Neurochem. 67 (1996) 463-472
27. Riikonen R. A long-term follow-up study of 214 children with the syndrome of infantile spasms. Neuropediatrics 13 (1982) 14-23
28. Riikonen R., and Amnell G. Psychiatric disorders in children with earlier infantile spasms. Dev. Med. Child. Neurol. 23 (1981) 747-760
29. Saemundsen E., Ludvigsson P., and Rafnsson V. Risk of autism spectrum disorders after infantile spasms: a population-based study nested in a cohort with seizures in the first year of life. Epilepsia 49 (2008) 1865-1870
30. Siegal T., Melamed E., Sandbank U., and Catane R. Early and delayed neurotoxicity of mitoxantrone and doxorubicin following subarachnoid injection. J. Neurooncol. 6 (1988) 135-140
31. Silverstein F., and Johnston M.V. Cerebrospinal fluid monoamine metabolites in patients with infantile spasms. Neurology 34 (1984) 102-105
32. Snead III O.C., Benton J.W., and Myers G.J. ACTH and prednisone in childhood seizure disorders. Neurology 33 (1983) 966-970
33. Stafstrom C.E., Moshe S.L., Swann J.W., Nehlig A., Jacobs M.P., and Schwartzkroin P.A. Models of pediatric epilepsies: strategies and opportunities. Epilepsia 47 (2006) 1407-1414
34. Stafstrom C.E. Infantile spasms: a critical review of emerging animal models. Epilepsy Curr. 9 (2009) 75-81
35. Turner C.A., Presti M.F., Newman H.A., Bugenhagen P., Crnic L., and Lewis M.H. Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behavior Genetics 31 (2001) 393-400
36. Uhler M., and Herbert E. Complete amino acid sequence of mouse pro opiomelanocortin derived from the nucleotide sequence of pro-opiomelanocortin cDNA. J. Biol. Chem. 258 (1983) 257-261
37. Velisek L., Jehle K., Asche S., and Veliskova J. Model of infantile spasms induced by N-methyl-d-aspartic acid in prenatally impaired brain. Ann. Neurol. 61 (2007) 109-119
38. Veliskova J., Claudio O.I., Galanopoulou A.S., Lado F.A., Ravizza T., Velisek L., and Moshe S.L. Seizures in the developing brain. Epilepsia 45 Suppl. 8 (2004) 6-12
39. Watanabe K. West syndrome: etiological and prognostic aspects. Brain Dev. 20 (1998) 1-8